Home › NCT05851430

Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry

Who can join

Ages 18 to 100 · All sexes

Inclusion Criteria:

1. Subject will undergo or has undergone PEF energy delivery utilizing Galvanize technology
2. Subject is expected to be available for follow-up per the enrolling physician's standard care practices
3. For prospective cohort, subject has a life expectancy of at least 3 months; for retrospective cohort, subject has completed at least three months of imaging following the PEF procedure
4. Signed informed consent is obtained, if required by IRB

Exclusion Criteria:

None

About the study

The goal of this observational registry is to assess the use and performance of Galvanize PEF technology in a real-world setting. The main questions it aims to answer are:

* PEF utilization and performance * Monitor safety outcomes and inform future generation devices.

Participants will undergo the PEF procedure and be followed per institutional standard of care.

What is being tested

• PEF ablation (device)

Sponsor: Galvanize Therapeutics, Inc. · Participants: 1,000 · Started: Jun 23, 2025

Contact the study team

• Partha Seshaiah, PhD · Phone: 650-268-4252

Official record on ClinicalTrials.gov — NCT05851430

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.